tirzepatide can't sleep Does Cause Insomnia​? Sleep and Weight Loss with

Some 18% of overweight Britons would be willing to pay for weight-loss drugs - but if they were available on the NHS, 59% said they would be keen on using them, according to new polling by communications agency Strand Partners

Safety and Long-Term Use GLP-1 medications have been used for diabetes for over a decade, with extensive safety data

For the majority of patients in clinical trials, tirzepatide resulted in greater weight loss and better blood sugar control due to its dual GIP and GLP 1 action

L., Madkour, H

Also, monitor your heart rate, organ function, mental effects, and side effects

Ozeki et al (2022) found that GLP1-RA semaglutide effectively reduces body adiposity while maintaining the skeletal muscle mass in obese Type 2 Diabetic patients. Xiang et al (2023) had similar findings, semaglutide can reduce the weight and fat of obese patients while effectively maintaining muscle mass and muscle strength. Chen et al (2023) conducted a 3-month intervention using dulaglutide in patients with Type 2 Diabetes, noting , dulaglutide intervention does not cause muscle and bone mass loss while inducing weight loss, and % change in body fat was independently associated with improved glucose control during dulaglutide therapy. With an increasing number of physicians and researchers relying on GLP-1 therapies for clinical care and research, it will continue to be crucial to track sensitive changes in body composition across different patient populations